Study S001027

GLP Analogs for Diabetes in Wolfram Syndrome Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01302327
Study type: INTERVENTIONAL
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2011-03-01
Primary completion: 2013-03-01
Lead sponsor: Hadassah Medical Organization
Conditions: Diabetes Mellitus Associated With Genetic Syndrome; Wolfram Syndrome
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

beta cell function [3 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0018487	GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome. Danielpur L, The Journal of clinical endocrinology and metabolism	2016	Case report	PMID 27459537 DOI	cites ClinicalTrials.gov:NCT01302327; registry reference DERIVED:27459537